Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
NCT01224782
·
clinicaltrials.gov ↗
COMPLETED
Status
994
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Secondary Hyperparathyroidism
Sponsor
AbbVie (prior sponsor, Abbott)